Massachusetts Institute of Technology
Sign in | Create Account

From Lab to Market: Where Technology is Headed

09/29/2004 9:45 AM Kresge
Rebecca M. Henderson, '81, Eastman Kodak LFM Professor of Management; Paul Horn, Senior Vice President and Director; IBM Research ; Uma Chowdhry, PhD '76, Vice President, Global Central Research and Development; DuPont ; ; Robert Tepper, President, Research and Development ; Millennium Pharmaceuticals

Description: How do you conduct R&D in a vanguard technology? These three panelists provide varying perspectives on the question. Paul Horn stands by IBM's longstanding commitment to its 5.5 billion dollar annual research effort, but with some caveats: "It's all about the speed of flowing new ideas into hardware, software and services," he says. You can't think about innovation without also considering "channels to market." IBM insists that "researchers spend time in the marketplace so they can understand how their technology can solve real world problems."

At DuPont, Uma Chowdhry cites a "quietly occurring transformation in the area of biobased materials." At two centuries' young, DuPont has a new primary challenge: "How do we transform from a petroleum-based economy to renewable resources such as crops?" Working with partners such as MIT, the company is exploring glucose, methane and nanotechnology to cook up new kinds of fuel, food supplements, and other products all economically. It's "a very big dream," acknowledges Chowdhry. The prerequisite, she says, is that "top management must have an unwavering commitment to the mission as well as time, vision and patience."

Robert Tepper describes the convergence of two revolutions driving his field forward. The complete sequencing of the human genome, combined with advances in understanding pathways of disease, will enable Millennium's researchers to create "breakthrough therapies." Scientists are already "making strides in cancer and inflammation," says Tepper. Millennium is linking up with industry, hospitals and academia, plumbing the genome to learn "why individuals are susceptible to disease."

Host(s): Office of the Provost, Technology Review

Tape #: 19004

Comments (0)

It looks like no one has posted a comment yet. You can be the first!

You need to log in, in order to post comments. If you don’t have an account yet, sign up now!

MIT World — special events and lectures

MIT World — special events and lectures

Category: Events | Updated 1 month ago

Created
December 12, 2011 19:31
Category
Tags
License
All Rights Reserved (What is this?)
Additional Files


Viewed
2326 times

More from MIT World — special events and lectures

Convocation Keynote (1)

Convocation Keynote (1)

Added 3 years ago | 00:49:53 | 1644 views

Reflections on the Current H1N1 Flu

Reflections on the Current H1N1 Flu

Added 3 years ago | 01:01:00 | 8830 views

Rebuilding New Orleans: An Opportunity to Re-Energize the Planning Profession?

Rebuilding New Orleans: An Opportun...

Added 3 years ago | 01:10:00 | 2492 views

Creatively Destroying New York: Fantasies, Premonitions, and Realities in the Provisional City

Creatively Destroying New York: Fan...

Added 3 years ago | 01:32:00 | 1989 views

The World Economy Blanchard, Caballero and Rigobon

The World Economy Blanchard, Caball...

Added 3 years ago | 01:22:00 | 1979 views

The Dignity of Difference

The Dignity of Difference

Added 3 years ago | 01:31:00 | 2750 views